Masao Tanaka

International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas

Masao Tanaka, Carlos Fernández-del Castillo, Volkan Adsay et al. · Pancreatology · 2012 · 2.3K citations

Medicine, Clinical Sciences, Diagnostic Pathology +7

Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)

Kamran Ghoreschi, Michael I. Jesson, Li Xiong et al. · The Journal of Immunology · 2011 · 644 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

Hideki Ueno, Tatsuya Ioka, Masafumi Ikeda et al. · Journal of Clinical Oncology · 2013 · 633 citations

Medicine, Oncology, Pharmacology +13

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

Hideki Ueno, T Kosuge, Y Matsuyama et al. · British Journal of Cancer · 2009 · 440 citations · Full text

Medicine, Oncology, Surgery +14

Japan Pancreatic Cancer Registry; 30th Year Anniversary

Shinichi Egawa, Hiroki Toma, Hiroaki Ohigashi et al. · Pancreas · 2012 · 431 citations

Medicine, Oncology, Surgery +17